Chaoju Eye Care Holdings (SEHK:2219) Stock Trails Profit Slip Despite Low P E

Chaoju Eye Care Holdings closed at HK$2.54 after a weak month for the stock, yet the H1 2026 earnings story is more nuanced than the recent drift suggests. Revenue reached ¥710.694m with basic earnings per share of ¥0.14, which keeps the trailing P/E near 8.2x, well below Hong Kong healthcare peers.

The real tension today sits between sentiment and valuation. The stock has slipped over the past 30 days but now sits against a report that keeps profit margins around 13.5% and leaves the apparent valuation gap to analyst fair value estimates wide open.

Is Chaoju Eye Care Holdings trading at a genuine discount, or masking deeper risks behind that low P/E and high yield? Compare the current market price to the full intrinsic value view in the valuation analysis for Chaoju Eye Care Holdings

H1 2026 Earnings Summary

• Revenue (H1 2026 vs H1 2025): ¥710.694m vs. ¥698.258m (broadly stable year on year)
• Net Income (Excl. Extra Items, H1 2026 vs H1 2025): ¥94.72m vs. ¥113.643m (decline in reported profit)
• Basic EPS (H1 2026 vs H1 2025): ¥0.14 vs. ¥0.164315 (decline in earnings per share)
• Net Profit Margin (TTM vs Prior Year): 13.5% vs. 13.9% (slight margin contraction over the year)

Prefer clean visual charts over another wall of earnings tables and ratios? Get a clear snapshot of Chaoju Eye Care Holdings, with its valuation picture highlighted, in the company report for Chaoju Eye Care Holdings.

Chaoju Eye Care Bullish Story Under Earnings Scrutiny

For investors leaning positive on Chaoju Eye Care, the latest numbers offer a mixed but still serviceable backdrop. Revenue for H1 2026 sits at ¥710.694m, broadly in line with H1 2025. That is consistent with a sector that often relies on steady, needs based demand. Net profit margin on a trailing basis is 13.5%, only slightly below 13.9%. For a specialized hospital platform, that stability suggests the basic ophthalmology model is still holding together, even if headline earnings per share have eased.

Profit Pressure Keeps Chaoju Bear Case Alive

The cautious view on Chaoju Eye Care also finds support in these results. Net income excluding extra items moved from ¥113.643m in H1 2025 to ¥94.72m in H1 2026. Basic EPS slipped from ¥0.164315 to ¥0.14. That points to pressure at the bottom line despite essentially flat revenue. With the share price down over the past 30 and 90 days, the market is already reacting to this softer profitability. For anyone worried about policy or competition squeezing private eye hospitals, these trends do not yet ease those concerns.

After a 9.54% dividend that is not well covered by free cash flows, it is worth asking whether Chaoju Eye Care Holdings has other structural weaknesses that could pressure future payouts. Review the independent risk analysis for Chaoju Eye Care Holdings which shows 1 important warning sign

Stay Ahead With Simply Wall St

If the mix of a low P/E and recent profit pressure at Chaoju Eye Care Holdings has your attention, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch how the story develops. After you decide to build or adjust a position, use the Portfolio Command Center to cut through market noise and see the key updates that matter to your holdings. For a broader view on what other investors are focusing on, tap into the Community and compare perspectives with a global investor base. This is a simple way to surface hidden catalysts or emerging risks early and stay ahead of the wider market.

Seeking Alternatives Beyond Chaoju Eye Care

Fresh ideas often move first and the market may respond later. Spot potential breakout momentum while it is still under the radar for now and consider acting early.

• Consider resilient compounding stories and scan a curated 309 resilient stocks with low risk scores list before others potentially catch on and bring these quieter performers into the spotlight.
• Monitor infrastructure-related opportunities and review the 38 power grid technology and infrastructure stocks while valuations and expectations still look reasonable enough for thoughtful investors to evaluate.
• Explore the potential second wave of AI enthusiasm and sort through 73 profitable AI stocks that aren't just burning cash that already combine the story with real earnings, rather than relying solely on hype and hope.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com